COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
Vaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Infectious Disease Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7449/13/2/41 |
id |
doaj-6fcfb2df9ca347f292e4d47c46384466 |
---|---|
record_format |
Article |
spelling |
doaj-6fcfb2df9ca347f292e4d47c463844662021-06-01T00:05:44ZengMDPI AGInfectious Disease Reports2036-74492021-05-01134142943610.3390/idr13020041COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for InnovationAbu Baker Sheikh0Suman Pal1Nismat Javed2Rahul Shekhar3Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USADepartment of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAShifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad 44000, PakistanDepartment of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USAVaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply are already evident with resource-rich nations having secured a large chunk of the available vaccine doses for 2021. Once supplies are made available, vaccines will have to be distributed and administered to entire populations—with considerations for individual risk level, remote geography, cultural and socio-economic factors. This would require logistical and trained personnel support that can be hard to come by for resource-poor nations. Several vaccines also require ultra-cold temperatures for storage and transport and therefore the need for specialized equipment and reliable power supply which may also not be readily available. Lastly, attention will need to be paid to ensuring adequate uptake of vaccines since vaccine hesitancy has already been reported for COVID vaccines. However, existing strengths of local and regional communities can be leveraged to provide innovative solutions and mitigate some of the challenges. Regional and international cooperation can also play a big role in ensuring equity in vaccine access and vaccination.https://www.mdpi.com/2036-7449/13/2/41vaccine equityhesitancyCOVAXdeveloping countries |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Abu Baker Sheikh Suman Pal Nismat Javed Rahul Shekhar |
spellingShingle |
Abu Baker Sheikh Suman Pal Nismat Javed Rahul Shekhar COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation Infectious Disease Reports vaccine equity hesitancy COVAX developing countries |
author_facet |
Abu Baker Sheikh Suman Pal Nismat Javed Rahul Shekhar |
author_sort |
Abu Baker Sheikh |
title |
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation |
title_short |
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation |
title_full |
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation |
title_fullStr |
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation |
title_full_unstemmed |
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation |
title_sort |
covid-19 vaccination in developing nations: challenges and opportunities for innovation |
publisher |
MDPI AG |
series |
Infectious Disease Reports |
issn |
2036-7449 |
publishDate |
2021-05-01 |
description |
Vaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass vaccination of the global population offers hope to curb the spread. Developing nations, however, face monumental challenges in procurement, allocation, distribution and uptake of vaccines. Inequities in vaccine supply are already evident with resource-rich nations having secured a large chunk of the available vaccine doses for 2021. Once supplies are made available, vaccines will have to be distributed and administered to entire populations—with considerations for individual risk level, remote geography, cultural and socio-economic factors. This would require logistical and trained personnel support that can be hard to come by for resource-poor nations. Several vaccines also require ultra-cold temperatures for storage and transport and therefore the need for specialized equipment and reliable power supply which may also not be readily available. Lastly, attention will need to be paid to ensuring adequate uptake of vaccines since vaccine hesitancy has already been reported for COVID vaccines. However, existing strengths of local and regional communities can be leveraged to provide innovative solutions and mitigate some of the challenges. Regional and international cooperation can also play a big role in ensuring equity in vaccine access and vaccination. |
topic |
vaccine equity hesitancy COVAX developing countries |
url |
https://www.mdpi.com/2036-7449/13/2/41 |
work_keys_str_mv |
AT abubakersheikh covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation AT sumanpal covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation AT nismatjaved covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation AT rahulshekhar covid19vaccinationindevelopingnationschallengesandopportunitiesforinnovation |
_version_ |
1721415779927195648 |